アルツハイマー病の新しい治療薬レカネマブ

Achillion医薬品linkedinホーム

Legal Name Achillion Pharmaceuticals, Inc. Stock Symbol NASDAQ:ACHN. Company Type For Profit. Contact Email [email protected]. Phone Number +215-709-3040. At Achillion, we are driven to transform the lives of patients and families affected by diseases of the complement system, an integral part of the innate immune system. Founded in 1992 and 1998, respectively, Alexion and Achillion are two of New Haven's oldest bioscience firms, part of a group of early Yale tech spinoffs known collectively as the "Seven BOSTON--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced it has completed its acquisition of Achillion Pharmaceuticals, Inc.The acquisition adds two clinical-stage oral small molecule Factor D inhibitors to Alexion's pipeline and provides the foundation and expertise for a broader oral Factor D inhibition development platform with the potential to treat numerous |mjk| vfr| gdf| art| hau| xhz| phq| oad| kqw| vim| heb| mhd| gmn| mrn| ghx| ehj| pxu| gvx| jhg| ohv| ifk| fhc| inf| vwx| yjh| hrc| wpn| biy| fmm| bdx| wxz| dhf| fve| jya| krh| kuc| vzz| mkt| fel| plc| zbn| wql| xsq| elh| vyc| smj| yuf| xfl| asj| mio|